Protocol No.UW26057
IMM1104-301
Principal InvestigatorUboha, Nataliya
PhaseIII
Age GroupAdult
ClinicalTrials.GovNCT07562152 (Click to jump to clinicaltrials.gov)
Management Group(s) Gastrointestinal

Title
A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination with the Modified Gemcitabine and nab-Paclitaxel Regimen Versus the Standard Gemcitabine and nab-Paclitaxel Regimen for the Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma Cancer (MAPKeeper 301)

Description

Objective

Treatment

Key Eligibility

Applicable Disease Sites
Pancreas

Participating Institutions
UW Health Eastpark Medical Center; UW Health University Hospital